Generic medications can be a viable alternative for some epilepsy patients. Those who are seeing good results from a particular formulation of a drug should remain on that formulation, whether it be generic or brand-name.
However, the decision to switch a patient to a different formulation should be left to the physician rather than to a well-meaning pharmacist attempting to save a patient money, or to an insurance company understandably looking to reduce costs.